Visual analysis is a key bottleneck in precision medicine. Aignostics believes that AI holds the key to discover the next generation of tissue-based biomarkers to drastically improve how cancer and other complex diseases are diagnosed and treated. Their mission is to support the discovery and validation of these biomarkers, and to develop them into diagnostic products for global use in clinics and labs.
Login or Register
You need to be logged in to use this feature.
Germany
Aignostics
2023
2023 Winner | Venture
Winner
Science Start-ups (Falling Walls Venture)
Content by this speaker
Explore more content of Falling Walls
Events with Aignostics
Falling Walls Venture Pitches – Session 3: Health Solutions
Further Activities to have a look at